4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-15-006720
CIK 0001316175operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 6:00 PM ET
Size
7.7 KB
Accession
0001214659-15-006720
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Award
Stock option (right to buy)
2015-09-17+60,000→ 60,000 totalExercise: $9.48Exp: 2025-09-17→ Common stock (60,000 underlying) - Award
Stock option (right to buy)
2015-09-17+30,000→ 30,000 totalExercise: $9.48Exp: 2025-09-17→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This stock option vests monthly over four years beginning December 30, 2014 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on September 17, 2025.
- [F2]This stock option vests monthly over four years beginning September 17, 2015 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on September 17, 2025.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 6:00 PM ET
- Size
- 7.7 KB